Glucagon-like peptide-1 receptor agonist treatment and risk of esophageal cancer. Akerstrom JH, Santoni G, von Euler-Chelpin M, Birgisson H, et al. Am J Gastroenterol 2025 Dec 12. doi: 10.14309/ajg.0000000000003885.

Read + Share

Amedeo Smart

Independent Medical Education

Akerstrom JH, Santoni G, von Euler-Chelpin M, Birgisson H, et al. Glucagon-like peptide-1 receptor agonist treatment and risk of esophageal cancer. Am J Gastroenterol 2025 Dec 12. doi: 10.14309/ajg.0000000000003885.
PMID: 41384845